SYMBOL:

    Up to 100 tickers separated by a space
Site Map FAQ Contact us Home Personalize
Company
Industry
Earnings
US Markets
Most Active
Portfolio
Tools
ETFs
Ratings
ANAVEX LIFE SCIENCES CORP
(NQPK:AVXL Last Sale: 3.28 +0)
Fundamentals Charts Tech Analysis Industry Earnings
Company Profile   Details


NQPK: (AVXL : $3.28)
$192,421 million Market Cap at Market Close, July 1, 2022
Drugs SubIndustry up .00% / Health Industry up .00% Today
Vancouver, BC Research Report Earnings Snapshot - Last 12/22/15
Canada Fact Sheet
Financial Statements
Peer Comparison


Drug discovery platform with a broad IP portfolio based on sigma receptors ligands. ANAVEX 2-73 has succesfully completed a Phase 1 single ascending dose clinical trial of ANAVEX 2-73, lead drug candidate for the treatment of Alzheimer’s Disease (AD).
Historical Charts    Technical Analysis
No Historical Data available for AVXL

Type of Stock Symbol Last Sale Last Close Net +/- % +/- Low High Volume 52wk Low 52wk High Shares(M)
Common AVXL $3.28 $3.28 0 .0 $3.15 $3.39 279,818 $3.15 $3.39 58,664,946
Capitalization
Earnings Summary ()
*** No Earnings Available***
-10121
Common Stock $192,421,023

A
Google



QUICK NAVIGATION SITE SEARCH   Enter Keyword:
   
Home    Subscribe    Browser Help    Subscriber Services    B-to-B    Banks    Brokerage    Telco    Site Map    Legal    Contact/Email
Copyright © 1996 - 2024 Stock Smart with all rights reserved
Feed is currently being brought back up
Provided by Nanex